SG Americas Securities’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-14,586
Closed -$29K 3477
2026
Q1
$29K Buy
+14,586
New +$34.2K ﹤0.01% 3070
2025
Q3
Sell
-32,641
Closed -$163K 3445
2025
Q2
$163K Sell
32,641
-19,833
-38% -$86.1K ﹤0.01% 2388
2025
Q1
$231K Buy
+52,474
New +$246K ﹤0.01% 2430
2022
Q3
Sell
-10,625
Closed -$63K 3310
2022
Q2
$63K Buy
+10,625
New +$118K ﹤0.01% 3230
2021
Q4
Sell
-32,992
Closed -$1.35M 3544
2021
Q3
$1.35M Buy
+32,992
New +$1.2M 0.01% 1644

Other funds holding GDRX

SG Americas Securities's GDRX Position: Q2 2026 in Review

SG Americas Securities sold out of GoodRx Holdings (GDRX) in Q2 2026, closing a stake of 14,586 shares — an estimated $29K sold.

SG Americas Securities first reported a position in GDRX in Q3 2021 and held it in 5 quarters. The position peaked at $1.35M in Q3 2021. 162 funds tracked by Wall St. Rank hold GDRX as of Q2 2026.

  • SG Americas Securities reported no remaining GoodRx Holdings position as of Q2 2026 after selling out during the quarter.
  • SG Americas Securities sold 14,586 GoodRx Holdings shares in Q2 2026, an estimated $29K.
  • SG Americas Securities first reported a position in GoodRx Holdings in Q3 2021 and held it in 5 quarters.
  • SG Americas Securities's GoodRx Holdings position peaked at $1.35M in Q3 2021.
  • 162 funds tracked by Wall St. Rank held GoodRx Holdings as of Q2 2026.

Based on SG Americas Securities's 13F filing for Q2 2026, filed 7 Aug 2026.